Pros | - | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | - | - |
INDMoney rank | - | 1/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 4 Years 2 Months | 7 Years 7 Months | ||
Fund AUM | ₹231 Cr | ₹6460 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.47% | 1.02% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | Nifty Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 41 | 41 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (12.73%) Divi's Laboratories Ltd (8.75%) Apollo Hospitals Enterprise Ltd (6.12%) Max Healthcare Institute Ltd Ordinary Shares (6.08%) Torrent Pharmaceuticals Ltd (4.26%) | Sun Pharmaceuticals Industries Ltd (12.83%) Dr Reddy's Laboratories Ltd (9.81%) Cipla Ltd (8%) Divi's Laboratories Ltd (7.48%) Aurobindo Pharma Ltd (6.04%) | ||
No of Sectors | 4 | 3 | ||
Top 3 Sectors | Health (95.52%) Basic Materials (2.18%) Financial Services (1.3%) | Health (97.66%) Basic Materials (1.19%) Financial Services (1.15%) | ||
Equity % | 97.28% | 97.7% | ||
Debt % | - | - | ||
P/E | 42.99 | 31.48 | ||
P/B | 5.89 | 4.31 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.51% | 0.25% | ||
3-Month Return | -0.64% | 1.85% | ||
6-Month Return | -3.67% | 0.97% | ||
1-Year Return | -6.37% | 2.18% | ||
3-Year Return | 21.74% | 29.18% | ||
5-Year Return | - | 18.6% |
Sharpe | 0.9 | 1.3 | ||
Alpha | -0.37 | 4.06 | ||
Beta | 0.91 | 0.95 | ||
Standard Deviation | 15.64 | 15.54 | ||
Information Ratio | -0.42 | 1.28 |
Description | ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rohan Korde, Dhimant Shah | Dharmesh Kakkad, Sharmila D’mello |